Front. Mol. Neurosci., 2020 · DOI: 10.3389/fnmol.2019.00326 · Published: January 10, 2020
Spinal cord injury (SCI) is mostly caused by trauma, leading to permanent neurological impairment. The primary mechanical injury is unavoidable, necessitating a focus on secondary injury mechanisms. Transfer RNA-derived small RNAs (tsRNAs) are short, non-coding RNAs with potential regulatory functions in various diseases. Their roles in traumatic SCI were investigated using sequencing, qRT-PCR, bioinformatics, and luciferase reporter assays. The study identified an altered tsRNA expression pattern and predicted that tiRNA-Gly-GCC-001 might be involved in the MAPK and neurotrophin pathways by targeting BDNF, thus regulating the post-SCI pathophysiologic processes.
tsRNAs, specifically tiRNA-Gly-GCC-001, represent novel molecular targets for the clinical therapy of SCI.
tsRNA expression profiles may serve as potential biomarkers for assessing the severity and progression of SCI.
Modulating the MAPK and neurotrophin signaling pathways via tsRNA-based interventions could offer new therapeutic avenues for SCI.